Ginkgo bioworks announces date of third quarter 2023 results presentation

Presentation and q&a session scheduled for post-market on wednesday, november 8, 2023 boston , nov. 1, 2023 /prnewswire/ -- ginkgo bioworks (nyse: dna), which is building the leading platform for cell programming and biosecurity, today announced that it plans to host a presentation and q&a session reviewing business performance for the third quarter ended september 30, 2023, on wednesday, november 8, 2023, beginning at 5:30 p.m. et. the presentation details and webcast link will be available on ginkgo's investor relations website at https://investors.ginkgobioworks.com, and a replay will be made available.
DNA Ratings Summary
DNA Quant Ranking